Skip to Content

ER 5 3.0 (Pramipexole Dihydrochloride Extended-Release 3.0 mg)

Pill with imprint ER 5 3.0 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 3.0 mg. It is supplied by Macleods Pharmaceuticals Limited.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 3.0 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 5 3.0

Pramipexole Dihydrochloride Extended-Release

ER 5 3.0
3.0 mg
Elliptical / Oval
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.